# Embla Medical hf. (OSSUY)

> Healthcare · IS · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/OSSUY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 232.40M | $ 14.46M | $ 3.87M | $ 552.94M | $ 899.32M |
| 2025 | $ 951.71M | $ 85.38M | $ 117.82M | $ 695.19M | $ 890.70M |
| 2024 | $ 898.56M | $ 71.77M | $ 93.58M | $ 499.79M | $ 777.19M |
| 2023 | $ 849.52M | $ 63.13M | $ 70.38M | $ 467.73M | $ 701.88M |
| 2022 | $ 802.81M | $ 47.49M | $ 49.40M | $ 480.92M | $ 635.70M |
| 2021 | $ 854.25M | $ 76.07M | $ 99.34M | $ 448.15M | $ 621.59M |
| 2020 | $ 801.94M | $ 7.92M | $ 99.97M | $ 483.39M | $ 572.51M |
| 2019 | $ 885.80M | $ 85.24M | $ 97.48M | $ 360.22M | $ 564.37M |
| 2018 | $ 809.42M | $ 105.33M | $ 69.20M | $ 235.48M | $ 534.46M |
| 2017 | $ 790.28M | $ 79.95M | $ 79.86M | $ 158.69M | $ 499.92M |
| 2016 | $ 738.60M | $ 72.48M | $ 59.11M | $ 155.65M | $ 469.83M |
| 2015 | $ 678.20M | $ 71.95M | $ 65.69M | $ 84.10M | $ 461.94M |
| 2014 | $ 719.73M | $ 84.00M | $ 103.33M | $ 122.29M | $ 440.83M |
| 2013 | $ 620.49M | $ 57.58M | $ 75.85M | $ 150.75M | $ 446.65M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.61 |
| Liabilities / Eq | 0.89 |
| Current Ratio | 1.21 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 7.93 |
| Gross Debt / FCF | 6.64 |

## Other views

- [Metrics](https://sponda.capital/en/OSSUY.md)
- [Charts](https://sponda.capital/en/OSSUY/charts.md)
- [Compare](https://sponda.capital/en/OSSUY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.